Nasrollahpour, H. Et Al. 2021. Ultrasensitive bioassaying of HER-2 protein for diagnosis of breast cancer using reduced graphene oxide/chitosan as nanobiocompatible platform. CANCER NANOTECHNOLOGY , vol.12, no.1 .

Nasrollahpour, H., IŞILDAK, İ., Rashidi, M., Hashemi, E. A., Naseri, A., & Khalilzadeh, B., (2021). Ultrasensitive bioassaying of HER-2 protein for diagnosis of breast cancer using reduced graphene oxide/chitosan as nanobiocompatible platform. CANCER NANOTECHNOLOGY , vol.12, no.1.

Nasrollahpour, Hassan Et Al. "Ultrasensitive bioassaying of HER-2 protein for diagnosis of breast cancer using reduced graphene oxide/chitosan as nanobiocompatible platform," CANCER NANOTECHNOLOGY , vol.12, no.1, 2021

Nasrollahpour, Hassan Et Al. "Ultrasensitive bioassaying of HER-2 protein for diagnosis of breast cancer using reduced graphene oxide/chitosan as nanobiocompatible platform." CANCER NANOTECHNOLOGY , vol.12, no.1, 2021

Nasrollahpour, H. Et Al. (2021) . "Ultrasensitive bioassaying of HER-2 protein for diagnosis of breast cancer using reduced graphene oxide/chitosan as nanobiocompatible platform." CANCER NANOTECHNOLOGY , vol.12, no.1.

@article{article, author={Hassan Nasrollahpour Et Al. }, title={Ultrasensitive bioassaying of HER-2 protein for diagnosis of breast cancer using reduced graphene oxide/chitosan as nanobiocompatible platform}, journal={CANCER NANOTECHNOLOGY}, year=2021}